Management of Pediatric Pancreatic Calculi At a Single Center: a Retrospective Cohort Study
A Single-Center Retrospective Cohort Study Evaluating the Management and Outcomes of Pediatric Pancreatic Duct Stones Using Endoscopic and Surgical Techniques
1 other identifier
observational
60
0 countries
N/A
Brief Summary
The goal of this observational study is to evaluate the long-term effects of ERCP and surgery in pediatric patients with pancreatic duct stones. The main objective is to determine the optimal treatment choice(ERCP or surgery) for children with pancreatic duct stones and identify the appropriate timing for surgery in patients who have undergone multiple ERCP procedures, in order to avoid adverse outcomes caused by repeated trauma to the duodenal papilla. Last updated on January 24, 2025.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2025
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 23, 2025
CompletedFirst Posted
Study publicly available on registry
March 28, 2025
CompletedStudy Start
First participant enrolled
April 23, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 23, 2025
CompletedMarch 28, 2025
March 1, 2025
8 months
March 23, 2025
March 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
stone clearance
The stone clearance rate refers to the proportion of patients confirmed by postoperative imaging (MRCP) to have no residual pancreatic duct stones.
From intervention to the end of treatment at 1 week
complication rate
The complication rate refers to the incidence of pancreatitis following ERCP and associated procedures, as well as pancreatic fistula, bile leakage, and the necessity for prolonged drainage after the Frey procedure.
From enrollment to the end of treatment at 2 weeks
reintervention rate
The reintervention rate refers to the proportion of patients who required additional invasive procedures (either ERCP or surgery) after the initial treatment.
From enrollment to the end of treatment at 1 year.
Study Arms (2)
ERCP group
Pediatric pancreatic duct stone patients who underwent ERCP to restore pancreatic duct patency.
Surgery group
Pediatric pancreatic duct stone patients who underwent Frey surgery.
Interventions
There are two intervention methods for pediatric pancreatic duct stones. One is to remove the pancreatic duct stones through Endoscopic Retrograde Cholangiopancreatography(ERCP), while simultaneously dilating the pancreatic duct and placing a stent to assist in the normal drainage of pancreatic juice. The other is local resection of the pancreatic head combined with longitudinal pancreaticojejunostomy (Frey surgery).
Eligibility Criteria
Children and adolescents (≤18 years old) diagnosed with pancreatic duct stones between 2015 and 2025 at a single tertiary care center. Data includes patients who underwent ERCP or surgery when the first treatment.
You may qualify if:
- Patients aged 0 to 18 years
- Diagnosed with pancreatic duct stones by imaging (e.g., ultrasound, CT, MRCP)
- Treated and followed at pediatric surgery, west china hospital, between 2014 and 2025
- Complete clinical data available for review
You may not qualify if:
- Pancreatic duct stones secondary to previous pancreatic or biliary surgery
- Concurrent severe systemic diseases (e.g., advanced cardiac, renal, or hepatic disease)
- Incomplete or missing key clinical records
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yifan Denglead
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- M.Med
Study Record Dates
First Submitted
March 23, 2025
First Posted
March 28, 2025
Study Start
April 23, 2025
Primary Completion
December 23, 2025
Study Completion
December 23, 2025
Last Updated
March 28, 2025
Record last verified: 2025-03